{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:52Z","timestamp":1790014852453,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ebiom.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T17:50:58Z","timestamp":1551203458000},"page":"636-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction"],"prefix":"10.1016","volume":"41","author":[{"given":"Fiona C.","family":"Brownfoot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevvandi","family":"Senadheera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tuohey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5728","key":"10.1016\/j.ebiom.2019.02.013_bb0005","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"issue":"9461","key":"10.1016\/j.ebiom.2019.02.013_bb0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.013_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.013_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.ebiom.2019.02.013_bb0025","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2019.02.013_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"10.1016\/j.ebiom.2019.02.013_bb0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"13","key":"10.1016\/j.ebiom.2019.02.013_bb0040","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2019.02.013_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12884-016-0902-3","article-title":"Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta","volume":"16","author":"Brownfoot","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0060","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: Effects on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin secretion, and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.013_bb0065","doi-asserted-by":"crossref","first-page":"388.e1","DOI":"10.1016\/j.ajog.2018.07.019","article-title":"Esomeprazole to treat women with preterm preeclampsia: a randomised placebo controlled trial","volume":"219","author":"Cluver","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.013_bb0070","first-page":"2505","article-title":"Expression of inflammatory cytokines in placentas from women with preeclampsia","volume":"86","author":"Benyo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.013_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","article-title":"Inflammation and pre-eclampsia","volume":"11","author":"Borzychowski","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2 Pt 1","key":"10.1016\/j.ebiom.2019.02.013_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.013_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/cvr\/cvp072","article-title":"Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia","volume":"82","author":"Kim","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.013_bb0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI992","article-title":"Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B","volume":"101","author":"Wahl","year":"1998","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ebiom.2019.02.013_bb0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.placenta.2014.06.374","article-title":"Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells","volume":"35","author":"Brownfoot","year":"2014","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.013_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","article-title":"Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin","volume":"4","author":"Tu'uhevaha","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ebiom.2019.02.013_bb0110","first-page":"1122","article-title":"Report of the american college of obstetricians and gynecologists' task force on hypertension in pregnancy","volume":"122","author":"ACOG","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.013_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nprot.2011.435","article-title":"Use of the mouse aortic ring assay to study angiogenesis","volume":"7","author":"Baker","year":"2012","journal-title":"Nat Protoc"},{"issue":"10","key":"10.1016\/j.ebiom.2019.02.013_bb0120","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1471-0528.2011.02962.x","article-title":"Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia","volume":"118","author":"Whitehead","year":"2011","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.013_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","article-title":"Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin","volume":"4","author":"Kaitu'u-Lino","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.013_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","article-title":"Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth","volume":"58","author":"Jebbink","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1095\/biolreprod.115.134460","article-title":"Jumonji domain containing protein 6 is decreased in human preeclamptic placentas and regulates sFLT-1 splice variant production","volume":"94","author":"Palmer","year":"2016","journal-title":"Biol Reprod"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajpath.2011.11.014","article-title":"MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin","volume":"180","author":"Kaitu'u-Lino","year":"2012","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.013_bb0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.115.05847","article-title":"Heme oxygenase-1 is not decreased in preeclamptic placenta and does not negatively regulate placental soluble fms-like tyrosine kinase-1 or soluble endoglin secretion","volume":"66","author":"Tong","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.013_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-2115(96)02647-4","article-title":"Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia","volume":"71","author":"Austgulen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.013_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/jmf.12.1.19.27","article-title":"Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia","volume":"12","author":"Chaiworapongsa","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.ebiom.2019.02.013_bb0160","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ Res"},{"issue":"10022","key":"10.1016\/j.ebiom.2019.02.013_bb0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2019.02.013_bb0170","doi-asserted-by":"crossref","first-page":"e7677","DOI":"10.1136\/bmj.e7677","article-title":"Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study","volume":"345","author":"Skjaerven","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.2004.00396.x","article-title":"Cardiovascular death in women who had hypertension in pregnancy: a case-control study","volume":"112","author":"Arnadottir","year":"2005","journal-title":"BJOG"},{"issue":"7323","key":"10.1016\/j.ebiom.2019.02.013_bb0180","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ebiom.2019.02.013_bb0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.013_bb0190","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/HYPERTENSIONAHA.114.03173","article-title":"Antenatal corticosteroids impact the inflammatory rather than the antiangiogenic profile of women with preeclampsia","volume":"63","author":"Nayeri","year":"2014","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ebiom.2019.02.013_bb0195","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1053-2498(99)00078-9","article-title":"Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants","volume":"18","author":"Feeley","year":"1999","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.013_bb0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-198510040-00001","article-title":"Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid","volume":"10","author":"Klotz","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ebiom.2019.02.013_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0954-6820.1963.tb16506.x","article-title":"Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid","volume":"173","author":"Hanngren","year":"1963","journal-title":"Acta Med Scand"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419300854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419300854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T10:30:13Z","timestamp":1572777013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419300854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":41,"alternative-id":["S2352396419300854"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.013","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}